Viewing nowNexgplitin Tablet 25 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Bionex Co., Ltd.

MFDS item code 202005612 · Approved 2020.08.03 · Insurance code 643105730
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. Initially, the medication may be administered alone, and if blood sugar control is difficult with monotherapy, it can be combined with metformin. Additionally, this medication can be used to improve blood sugar control when other diabetes medications such as sulfonylureas, metformin, thiazolidinediones, or insulin have been ineffective alone. It is a medication that is also used when blood sugar control is challenging with these combination therapies. Therefore, it is effective in improving blood sugar control alongside various medication therapies.
This medicine is administered at 100 mg once daily when used as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (refer to Precautions for Use, section 5. General Precautions). Patients with renal impairment As dose adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or patients with end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.
This medication may cause serious allergic reactions during use; therefore, if symptoms such as severe rash or swelling, difficulty breathing, etc. occur, stop taking the medication immediately and consult a doctor. This medication may induce pancreatitis, which is inflammation of the pancreas, so quickly inform healthcare professionals if symptoms such as abdominal pain, vomiting, or nausea occur. This medication should not be administered to patients with type 1 diabetes or diabetic ketoacidosis, nor should it be used in people who are allergic to this medication or its components. For patients with reduced renal function, dosage adjustments are necessary, so regular kidney function tests should be conducted and taken according to the doctor's instructions. During the use of this medication, symptoms of hypoglycemia may occur, especially when taken with insulin or sulfonylureas; therefore, blood sugar levels should be closely monitored, and medication dosages should be adjusted as needed. If severe joint pain or skin blistering symptoms occur during treatment, immediately inform a doctor and discontinue medication. It is advisable for pregnant or breastfeeding women not to use this medication, and safety and efficacy in children or adolescents under 18 years of age have not been established. In cases of overdose, standard treatment should be taken, and blood dialysis may be utilized for partial removal as directed by healthcare professionals. No significant interactions have been reported when used with other diabetes medications or certain cardiovascular drugs; however, it is essential to consult a doctor or pharmacist when taking other medications. For elderly patients, kidney function may decline, so it is important to regularly assess kidney function before and during use and adjust dosages accordingly.
Severe hypersensitivity reactions, anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, upper respiratory infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, rash, urticaria, cutaneous vasculitis, elevated liver enzyme levels, acute renal failure, arthralgia associated with severe and disability, bullous pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, dyspepsia, dizziness, increased serum triglycerides, gastritis, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container that prevents air from entering and should be kept at room temperature between 1 and 30 degrees Celsius to maintain its efficacy and safety.
Pink, round, biconvex, film-coated tablet
30 tablets - 10 tablets/PTP [x3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Bionex Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.